BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8622093)

  • 1. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.
    Bines J; Oleske DM; Cobleigh MA
    J Clin Oncol; 1996 May; 14(5):1718-29. PubMed ID: 8622093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles.
    Liem GS; Mo FK; Pang E; Suen JJ; Tang NL; Lee KM; Yip CH; Tam WH; Ng R; Koh J; Yip CC; Kong GW; Yeo W
    PLoS One; 2015; 10(10):e0140842. PubMed ID: 26485568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiles of lipids, blood pressure and weight changes among premenopausal Chinese breast cancer patients after adjuvant chemotherapy.
    Yeo W; Mo FKF; Pang E; Suen JJS; Koh J; Loong HHF; Yip CCH; Ng RYW; Yip CHW; Tang NLS; Liem GS
    BMC Womens Health; 2017 Jul; 17(1):55. PubMed ID: 28750616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants of age at menopause are not related to timing of ovarian failure in breast cancer survivors.
    Homer MV; Charo LM; Natarajan L; Haunschild C; Chung K; Mao JJ; DeMichele AM; Su HI
    Menopause; 2017 Jun; 24(6):663-668. PubMed ID: 28118297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Systemic Therapy on Fertility in Women with Early-Stage Breast Cancer.
    Natsuhara KH; Chien AJ
    Curr Breast Cancer Rep; 2024 Mar; 16(1):61-68. PubMed ID: 38645685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER2-positive is an independent indicator for predicting pathological complete response to neoadjuvant therapy and Ki67-changed after neoadjuvant chemotherapy predicts favorable prognosis in Chinese women with locally advanced breast cancer.
    Fang Y; Zhang Q; Wu Y; Wu J
    Medicine (Baltimore); 2024 Feb; 103(6):e37170. PubMed ID: 38335419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing attitudes related to future child-bearing in young women diagnosed with early-stage breast cancer.
    Umashankar S; Li M; Blevins K; Kim MO; Majure M; Park J; Huppert LA; Melisko M; Rugo HS; Esserman L; Chien AJ
    Breast Cancer Res Treat; 2024 Apr; 204(3):509-520. PubMed ID: 38194132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast Cancer.
    Kabirian R; Franzoi MA; Havas J; Coutant C; Tredan O; Levy C; Cottu P; Dhaini Mérimèche A; Guillermet S; Ferrero JM; Giacchetti S; Petit T; Dalenc F; Rouanet P; Everhard S; Martin AL; Pistilli B; Lambertini M; Vaz-Luis I; Di Meglio A
    JAMA Netw Open; 2023 Nov; 6(11):e2343910. PubMed ID: 37971739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menstrual blood-derived endometrial stem cell, a unique and promising alternative in the stem cell-based therapy for chemotherapy-induced premature ovarian insufficiency.
    Zhang S; Yahaya BH; Pan Y; Liu Y; Lin J
    Stem Cell Res Ther; 2023 Nov; 14(1):327. PubMed ID: 37957675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective longitudinal analysis of the predictors of amenorrhea after breast cancer chemotherapy: Impact of BRCA pathogenic variants.
    Oktay KH; Turan V; Bedoschi G; Abdo N; Bang H; Goldfarb S
    Cancer Med; 2023 Sep; 12(18):19225-19233. PubMed ID: 37698031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the benefit of gonadotropin-releasing hormone agonist treatment in premenopausal women undergoing hematopoietic cell transplantation.
    Han R; Song Z; Li H; Wang C; Zhang L; Yang X
    Sci Rep; 2023 Sep; 13(1):14497. PubMed ID: 37666835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chemotherapy and different chemotherapy regimens on bone health among Chinese breast cancer women in different menstrual status: a self-control study.
    Peng BQ; Wu J; Tian S; Qu XQ; Liang XY; Feng JH; Chen YL; She RL; Ma CY; Song JY; Li ZX; Jiang ZY; Wu KN; Kong LQ
    Support Care Cancer; 2023 Aug; 31(9):540. PubMed ID: 37642751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and self-reported markers of reproductive function in female survivors of childhood Hodgkin lymphoma.
    Drechsel KCE; Broer SL; Stoutjesdijk FS; Twisk JWR; van den Berg MH; Lambalk CB; van Leeuwen FE; Overbeek A; van den Heuvel-Eibrink MM; van Dorp W; de Vries ACH; Loonen JJ; van der Pal HJ; Kremer LC; Tissing WJ; Versluys B; Kaspers GJL; van Dulmen-den Broeder E; Veening MA;
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13677-13695. PubMed ID: 37522923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Systemic Oncological Treatments on the Fertility of Adolescents and Young Adults-A Systematic Review.
    Himpe J; Lammerant S; Van den Bergh L; Lapeire L; De Roo C
    Life (Basel); 2023 May; 13(5):. PubMed ID: 37240854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Random Start Ovarian Stimulation.
    Kumar P; Rao S; Mundkur A; Adiga P; Poojari VG; Ullagaddi RK
    J Hum Reprod Sci; 2022; 15(2):200-203. PubMed ID: 35928466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Treatment-Induced Bone Loss: Role of Denosumab in Non-Metastatic Breast Cancer.
    Dhabhar B
    Breast Cancer (Dove Med Press); 2022; 14():163-173. PubMed ID: 35860287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols.
    Balkenende EME; Dahhan T; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; Smeenk JMJ; Louwé LA; Cantineau AEP; de Bruin JP; Linn SC; van der Veen F; van Wely M; Goddijn M
    Hum Reprod; 2022 Jul; 37(8):1786-1794. PubMed ID: 35776109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-Induced Amenorrhea and Its Prognostic Significance in Premenopausal Women With Breast Cancer: An Updated Meta-Analysis.
    Wang Y; Li Y; Liang J; Zhang N; Yang Q
    Front Oncol; 2022; 12():859974. PubMed ID: 35463307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hormone receptor, HER2, and Ki-67 status conversions on survival after neoadjuvant chemotherapy in breast cancer patients: a retrospective study.
    Chen Y; Liu X; Yu K; Sun X; Xu S; Qiu P; Lv Z; Zhang X; Guo A; Xu Y
    Ann Transl Med; 2022 Jan; 10(2):93. PubMed ID: 35282081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Fertility Preservation Feasible and Safe With Neoadjuvant Therapy for Breast Cancer?
    Hershlag A; Mullin C; Bristow SL
    JCO Glob Oncol; 2020 Nov; 6():356-359. PubMed ID: 35275744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.